CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-26 | Avalon Ventures VII L P 10% owner | Sale | −37,040 | $24.35 | $902K | 0 |
| 2017-02-24 | Schoeneck James A Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-24 | Schmid John P. Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-24 | RENTON HOLLINGS Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-24 | Lydon Nicholas Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-24 | Gallagher Carol Giltner Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-24 | Topper James N Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-02-24 | Piscitelli Dominic Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2017-02-24 | MOYLE MATTHEW Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2017-02-24 | Londei Marco Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2017-02-24 | Suria Hamza President, CEO | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2017-02-02 | Frazier Healthcare VII, L.P. 10% owner | Option exercise | +117,235 | $4.55 | $533K | 2,345,612 |
| 2017-02-02 | Frazier Healthcare VII, L.P. 10% owner | Option exercise · Warrants | −117,235 | 0 | ||
| 2017-02-02 | Frazier Healthcare V, LP 10% owner | Option exercise | +117,235 | $4.55 | $533K | 2,345,612 |
| 2017-02-02 | Frazier Healthcare V, LP 10% owner | Option exercise · Warrants | −117,235 | 0 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion | +1,428,571 | 1,428,571 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion | +486,820 | 1,915,391 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion | +312,986 | 2,228,377 | ||
| 2017-01-31 | Novo A/S 10% owner | Conversion | +673,454 | 2,901,831 | ||
| 2017-01-31 | Novo A/S 10% owner | Option exercise | +81,673 | 2,983,504 |
Page 33 of 36 · 714 trades